Reckitt Benckiser (india) Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Reckitt Benckiser (india) Private Limited Pharmaceutical Export Portfolio Dataset — 5 Products, $28.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Reckitt Benckiser (india) Private Limited — Pharmaceutical Exporter Profile (2026) | 5 Products, $28.5M Trade | TransData Nexus

Reckitt Benckiser (india) Private Limited

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $28.5M Total Trade · DGFT Verified

Reckitt Benckiser (india) Private Limited is an Indian pharmaceutical exporter with a total trade value of $28.5M across 5 products in 3 therapeutic categories. Based on 2,032 verified export shipments from Indian Customs (DGFT) records, Reckitt Benckiser (india) Private Limited is the #1 Indian exporter in 3 products including Disprin, Aspirin, Salicylic. Top exports include Disprin ($10.6M), Aspirin ($6.0M), Salicylic ($5.8M).

Reckitt Benckiser (india) Private Limited — Export Portfolio & Destination Treemap

Reckitt Benckiser (india) Private Limited pharmaceutical export portfolio — 5 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Reckitt Benckiser (india) Private Limited? — Company Overview & Market Position

Reckitt Benckiser (India) Private Limited, established on July 5, 1951, is a subsidiary of Reckitt Benckiser Group plc, a British multinational consumer goods company. The company is registered in Haryana, India, with its corporate identification number (CIN) U74999HR1951PTC075277. Its registered office is located at DLF Cyber Park, 6th & 7th Floor (Tower C), 405 B, Udyog Vihar Phase III, Sector 20, Gurgaon, Haryana, 122016.

As of April 4, 2024, Reckitt Benckiser (India) Private Limited employed 1,772 individuals. The company's authorized capital is ₹100 crore, with a paid-up capital of ₹100 crore, indicating a robust financial foundation.

What Does Reckitt Benckiser (india) Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Disprin$10.6M 2Aspirin$6.0M

Product Portfolio — Top 5 by Export Value

Reckitt Benckiser (india) Private Limited exports 5 pharmaceutical products across 3 therapeutic categories. Market leader (#1 exporter) in 3 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Disprin	Brand Names & OTC Products	$10.6M	540	68.9%	1
2	Aspirin	Analgesics & Antipyretics	$6.0M	354	9.9%	1
3	Salicylic	Combination Drugs	$5.8M	350	21.5%	1
4	Moov	Brand Names & OTC Products	$4.5M	376	19.5%	2
5	Dettol	Brand Names & OTC Products	$1.5M	412	13.4%	2

Reckitt Benckiser (india) Private Limited exports 5 pharmaceutical products across 3 therapeutic categories with a total export value of $28.5M. The company is the #1 Indian exporter in 3 products: Disprin, Aspirin, Salicylic. The top category is Brand Names & OTC Products (58.6% of portfolio), followed by Analgesics & Antipyretics (21.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Reckitt Benckiser (india) Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Reckitt Benckiser (India) Private Limited operates manufacturing facilities in various locations, including Hosur, Tamil Nadu. The Hosur plant is situated in the SIPCOT Industrial Complex, near the ESI Bus Stop, Hosur, Tamil Nadu, 635126. While specific details regarding the capacities and specializations of these facilities are not publicly disclosed, the company's extensive product portfolio suggests a well-equipped manufacturing infrastructure capable of producing a diverse range of pharmaceutical formulations.

3Key Leadership

The leadership team of Reckitt Benckiser (India) Private Limited includes:

Gaurav Jain: Managing Director

Rajesh Kumar Jha: Additional Director

Chander Mohan Sethi: Director

These executives play pivotal roles in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Reckitt Benckiser (india) Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Reckitt Benckiser (India) Private Limited's products are subject to regulatory oversight in key markets such as the United States, European Union, United Kingdom, Australia, and Japan. While specific details regarding regulatory filings, approvals, and market access status are not publicly available, the company's association with Reckitt Benckiser Group plc, a globally recognized entity, suggests adherence to international regulatory standards. This affiliation likely facilitates smoother market entry and compliance with regulatory requirements in these regions.

2Emerging Markets

Reckitt Benckiser (India) Private Limited has a presence in emerging markets, including Africa, Latin America, and Southeast Asia. The company's products, such as Dettol and Disprin, are well-established in these regions, indicating a strong market penetration. While specific details regarding WHO prequalification are not available, the company's global footprint and product acceptance suggest compliance with international quality standards, facilitating access to these markets.

3Geographic Strategy

Reckitt Benckiser (india) Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Reckitt Benckiser (India) Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. However, the company's association with Reckitt Benckiser Group plc, a globally recognized entity, suggests adherence to international regulatory standards, including those set by the FDA.

2WHO & EU GMP

While specific information regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certificates for Reckitt Benckiser (India) Private Limited is not publicly available, the company's global operations and product acceptance in various markets imply compliance with international quality standards. This adherence likely includes WHO prequalification and EU GMP certifications, facilitating access to these markets.

3CDSCO & Indian Regulatory

Reckitt Benckiser (India) Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), ensuring compliance with Indian regulatory standards. The company's products are approved by state drug controllers, and it possesses the necessary export No Objection Certificates (NOCs), facilitating international trade.

Reckitt Benckiser (india) Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the analgesics and over-the-counter (OTC) products segment, Reckitt Benckiser (India) Private Limited faces competition from companies such as Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Ltd., and Lupin Ltd. Reckitt's market leadership in products like Disprin, Aspirin, and Salicylic acid underscores its strong competitive position. The company's focus on brand names and OTC products, comprising 58.6% of its portfolio, further solidifies its standing in the market.

2Key Differentiators

Reckitt Benckiser (India) Private Limited's key differentiators include its strong brand portfolio, with market-leading products such as Disprin, Aspirin, and Salicylic acid. The company's focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, distinguishes it from competitors dealing with raw active pharmaceutical ingredients (APIs). This specialization allows Reckitt to offer comprehensive therapeutic solutions to consumers.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Reckitt Benckiser (india) Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Reckitt Benckiser (India) Private Limited has a commendable track record in the pharmaceutical industry, with a total export value of $28.5 million USD and 2,032 shipments across five products in three therapeutic categories. The company's portfolio concentration, with the top five products accounting for 100% of exports, indicates a focused and reliable supply chain. The absence of recent regulatory actions further underscores the company's reliability and commitment to quality.

2Certifications to Verify

Importers should verify the following certifications when engaging with Reckitt Benckiser (India) Private Limited:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration to ensure compliance with U.S. regulations.

WHO-GMP Certification: Verify the company's adherence to World Health Organization Good Manufacturing Practices, ensuring product quality and safety.

Frequently Asked Questions — Reckitt Benckiser (india) Private Limited

How many pharmaceutical products does Reckitt Benckiser (india) Private Limited export from India?

Reckitt Benckiser (india) Private Limited exports 5 pharmaceutical products across 3 therapeutic categories. The top exports are Disprin ($10.6M), Aspirin ($6.0M), Salicylic ($5.8M), Moov ($4.5M), Dettol ($1.5M). Total export value is $28.5M.

What is Reckitt Benckiser (india) Private Limited's total pharmaceutical export value?

Reckitt Benckiser (india) Private Limited's total pharmaceutical export value is $28.5M, based on 2,032 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Reckitt Benckiser (india) Private Limited the #1 Indian exporter?

Reckitt Benckiser (india) Private Limited is the #1 Indian exporter in 3 products: Disprin (68.9% market share), Aspirin (9.9% market share), Salicylic (21.5% market share).

What therapeutic categories does Reckitt Benckiser (india) Private Limited cover?

Reckitt Benckiser (india) Private Limited exports across 3 therapeutic categories. The largest are Brand Names & OTC Products (58.6%, 3 products), Analgesics & Antipyretics (21.0%, 1 products), Combination Drugs (20.5%, 1 products).

Get Full Reckitt Benckiser (india) Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.